Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 14;39(1):47-49.
doi: 10.3760/cma.j.issn.0253-2727.2018.01.010.

[Anti-CD19 chimeric antigen receptors T cells for treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: three cases report and literatures review]

[Article in Chinese]
Affiliations

[Anti-CD19 chimeric antigen receptors T cells for treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: three cases report and literatures review]

[Article in Chinese]
F Yang et al. Zhonghua Xue Ye Xue Za Zhi. .
No abstract available

PubMed Disclaimer

Similar articles

References

    1. Crist WM, Carroll AJ, Shuster JJ, et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study[J] Blood. 1990;76(1):117–122. - PubMed
    1. Rambaldi A, Attuati V, Bassan R, et al. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia[J] Leuk Lymphoma. 1996;21(5-6):457–466. doi: 10.3109/10428199609093444. - DOI - PubMed
    1. Vey N, Thomas X, Picard C, et al. Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study[J] Leukemia. 2006;20(12):2155–2161. doi: 10.1038/sj.leu.2404420. - DOI - PubMed
    1. 中华医学会血液学分会, 中国抗癌协会血液肿瘤专业委员会. 中国成人急性淋巴细胞白血病诊断与治疗专家共识[J] 中华血液学杂志. 2012;33(9):789–792. doi: 10.3760/cma.j.issn.0253-2727.2012.09.028. - DOI - PubMed
    1. Saltman D, Barlev A, Seshagiri D, et al. Management and treatment of relapsed or refractory Ph(-)B-precursor ALL: a web-based, double-blind survey of EU clinicians[J] BMC Cancer. 2015;15:771. doi: 10.1186/s12885-015-1745-4. - DOI - PMC - PubMed